In a significant number of patients, MASLD coexists with other dysmetabolic traits, such as obesity and type 2 diabetes mellitus (T2DM), suggesting that MASLD is the hepatic manifestation of the metabolic syndrome (MetS), impacting approximately 30% of the global adult population [2, 3]
Vincents Hospital Sydney, Australia Reviewed by Raffaele Carraro, La Princesa University Hospital, Spain Laura Marroqui, Miguel Hernndez University of Elche, Spain Updates Copyright 2024 Corrao, Pollicino, Maggio, Torres and Argano
Ma et al, 2005)
The loading phase is the most intensive part of the protocol in terms of injection frequency
It is worth noting that clinical services should not be solely diagnosis oriented but should provide step-by-step specific interventions
Your progress compared to your own baseline matters more than hitting arbitrary benchmarks